Skip to main content

Regenerative Medicine

Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Pune, India – – September 22, 2026 -- The global exosomes market is set to grow nearly tenfold over the next decade, expanding from USD 230.55 million in 2025 to USD 2,250 million by 2034, according to a new analysis from Maximize Market Research. The projected 28.8% compound annual growth rate between 2026 and 2034 places exosome technology among the fastest-expanding segments in biopharmaceutical R&D.

Drug delivery pipelines drive commercial momentum

Pharmaceutical and biotechnology companies are expanding exosome-related pipelines as the nanosized extracellular vesicles gain traction as targeted carriers for drugs, proteins, and RNA. Rising investment in biotechnology and advances in isolation, characterization, and engineering technologies are pushing exosomes beyond research settings into drug development and regenerative medicine applications.

Eterna Regeneratives Raises Seed Funding for Keratin Enamel Repair Tech

Eterna Regeneratives Raises Seed Funding for Keratin Enamel Repair Tech

London – September 19, 2026 -- UK biotech spin-out Eterna Regeneratives has closed a seed funding round led by Hoxton Ventures and The Venture Collective to commercialize a keratin-based material that regrows tooth enamel, targeting the $43 billion global oral care market.

King's College London spin-out moves from lab to commercial pipeline

Co-founded in 2024 by Khaled Eissa and Dr Sherif Elsharkawy, Eterna emerged from research led by Elsharkawy and PhD student Dr Sara Gamea that drew coverage from the BBC, Washington Post and Newsweek after demonstrating keratin's capacity to regrow damaged enamel. The seed round funds the shift from proof-of-concept research to real-world product development, according to Elsharkawy, the company's Chief Scientific Officer.